Fungal allergy in asthma-state of the art and research needs
Open accessThe DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Abstract
Sensitization to fungi and long term or uncontrolled fungal infection are associated with poor control of asthma, the likelihood of more severe disease and complications such as bronchiectasis and chronic pulmonary aspergillosis. Modelling suggests that >6.5 million people have severe asthma with fungal sensitizations (SAFS), up to 50% of adult asthmatics attending secondary care have fungal sensitization, and an estimated 4.8 million adults have allergic bronchopulmonary aspergillosis (ABPA). There is much uncertainty about which fungi and fungal allergens are relevant to asthma, the natural history of sensitisation to fungi, if there is an exposure response relationship for fungal allergy, and the pathogenesis and frequency of exacerbations and complications. Genetic associations have been described but only weakly linked to phenotypes. The evidence base for most management strategies in ABPA, SAFS and related conditions is weak. Yet straightforward clinical practice guidelines for management are required. The role of environmental monitoring and optimal means of controlling disease to prevent disability and complications are not yet clear. In this paper we set out the key evidence supporting the role of fungal exposure, sensitisation and infection in asthmatics, what is understood about pathogenesis and natural history and identify the numerous areas for research studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Patterns of fungal interactions with humans, illustrating different host pathogen interactions, based on the host damage response framework[9].](https://figures.cochat.ai/paper-figures/b9f6eead36974711a77ef2b7657e5597/fungal-allergy-in-asthma-state-of-the-art-and-research-needs-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mean ABPA prevalence rate of 2.5% in adult asthmatics reflects studies done in new asthma referrals to a specialist in South Africa, New Zealand, Iran, Ireland, Saudi Arabia and China, translating to over 4.8 million cases of ABPA in adults [137].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [137]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291 · cited 1×
“The Global Burden of Disease 2010 project estimated that asthma wa s ranked 43rd globally for years life lost [62], although 15th and 20th in Oceania and Easter n Europe respectively; 15th globally in terms of prevalence with an estimated 334 million people affected; 14th in terms of years lived with disability [63];…”
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987 · cited 1×
“Bio-statistical approaches to measuring heterogeneity in asthma have suggested that asthma as broadly defined is comprised of a number of distinct endotypes, not all of which have obvious AHR or variable airflow obstruction [11,12], and improvement in symptoms of asthma are not always reflected in better physiological…”
BackgroundSelf-citationDisordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., Pachter, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,824
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
Johansson, S. G. O., Hourihane, J. O., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T., Kowalski, M. L., Mygind, N., Ring, J., van Cauwenberge, P., et al. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.t01-1-00001.x · Cited by 1,723 · cited 1×
“As fungi are complex eukaryotes, all forms of allergic immune response [8] should be considered as potentially leading to fungal allergy, although the most well-recognised clinical responses, such as asthma and rhinitis caused by Alternaria alternata, are mediated in a straightforward immunoglobulin (Ig) E/ TH2 manner.”
BackgroundUrban, C. F., Ermert, D., Schmid, M., Abu-Abed, U., Goosmann, C., Nacken, W., Brinkmann, V., Jungblut, P. R., & Zychlinsky, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000639 · Cited by 1,673 · cited 1×
“Macrophages phagocytose fungi, neutrophils phagocytose and/ or release their granule contents and form DNA neutrophil extracellular traps (NETs) to entangle, immobilize and kill the fungus, a process involving neutrophilderived calprotectin [118,119].”
BackgroundAsthma endotypes: A new approach to classification of disease entities within the asthma syndrome
Lötvall, J., Akdis, C. A., Bacharier, L. B., Bjermer, L., Casale, T. B., Custovic, A., Lemanske, R. F., Wardlaw, A. J., Wenzel, S. E., & Greenberger, P. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.037 · Cited by 1,160 · cited 2×
“While ABPA was accepted as an endotype of asthma by another EAACI Task Force [12], SAFS was not and remains a pragmatic definition to enable an antifungal therapy trial.”
BackgroundSelf-citationChronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) · Science · doi:10.1126/science.1200439 · Cited by 1,056 · cited 1×
“Autosomal recessive IL-17RA and autosomal dominant IL-17F deficiencies have been reported in chronic mucocutaneous candidiasis (CMC) patients [131].”
BackgroundGlucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983 · cited 1×
“Parenteral steroids may be required for ABPA unresponsive to oral steroids and antifungals, and may down-regulate steroid receptors [194].”
BackgroundAspergillus flavus: human pathogen, allergen and mycotoxin producer
Hedayati, M. T., Pasqualotto, A. C., Warn, P. A., Bowyer, P., & Denning, D. W. (2007) · Microbiology · doi:10.1099/mic.0.2007/007641-0 · Cited by 964
Self-citationAgarwal, R., Chakrabarti, A., Shah, A., Gupta, D., Meis, J. F., Guleria, R., Moss, R., Denning, D. W., & ABPA complicating asthma ISHAM working group (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12141 · Cited by 896 · cited 4×
“a = often referred to as RAST tests, although the original radioallergoabsorbent test and a simpler definition of ABPA (see Table 1) [5].”
BackgroundInfluentialSelf-citationActivation of the innate immune receptor Dectin-1 upon formation of a ‘phagocytic synapse’
Goodridge, H. S., Reyes, C. N., Becker, C. A., Katsumoto, T. R., Ma, J., Wolf, A. J., Bose, N., Chan, A. S. H., Magee, A. S., Danielson, M. E., et al. (2011) · Nature · doi:10.1038/nature10071 · Cited by 867 · cited 1×
“Activation of these receptors by whole fungi through a proposed ‘phagocytic synapse’ [142] or fungal components (prototypically ßglucans) elicit anti-fungal effector activities, that are (opsono)phagocytosis, cytokine production and respiratory burst.”
BackgroundThe link between fungi and severe asthma: A summary of the evidence
Denning, D. W., O'Driscoll, B. R., Hogaboam, C. M., Bowyer, P., & Niven, R. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00074705 · Cited by 824 · cited 1×
“In 2006, the term severe asthma with fungal sensitisation (SAFS) was introduced [26] and subsequently shown to be responsive to antifungal therapy [27].”
BackgroundSelf-citationClinical and Immunologic Criteria for the Diagnosis of Allergic Bronchopulmonary Aspergillosis
ROSENBERG, M., PATTERSON, R., MINTZER, R., COOPER, B. J., ROBERTS, M., & HARRIS, K. E. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-4-405 · Cited by 819 · cited 1×
“ABPA was first described in 1952 [13], and the criteria for diagnosis were defined during the 1970s and 1980s [14-17].”
BackgroundA Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Glocker, E.-O., Hennigs, A., Nabavi, M., Schäffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810719 · Cited by 800 · cited 3×
“The pathophysiological and clinical disease relevance of these receptors is corroborated by the finding that genetic mutations in distinct CLRs, namely dectin-1 [144] and CARD9 [145], cause CMC and other fungal infections.”
BackgroundSurface hydrophobin prevents immune recognition of airborne fungal spores
Aimanianda, V., Bayry, J., Bozza, S., Kniemeyer, O., Perruccio, K., Elluru, S. R., Clavaud, C., Paris, S., Brakhage, A. A., Kaveri, S. V., et al. (2009) · Nature · doi:10.1038/nature08264 · Cited by 792 · cited 1×
“Our supposition is that fungal airway infection induces an ongoing allergic stimulus, as although most fungal conidia (spores) release some allergen(s), many more are produced after spore swelling and germination [36]; before germination the conidia are covered in hydrophobin proteins, which elicit no immune reaction…”
BackgroundBroncho-pulmonary Aspergillosis : A Review and a Report of Eight New Cases
Hinson, K. F. W., Moon, A. J., & Plummer, N. S. (1952) · Thorax · doi:10.1136/thx.7.4.317 · Cited by 790 · cited 1×
“ABPA was first described in 1952 [13], and the criteria for diagnosis were defined during the 1970s and 1980s [14-17].”
BackgroundStevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., Judson, M. A., Denning, D. W., Crameri, R., Brody, A. S., Light, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376525 · Cited by 790 · cited 1×
“Other consensus reviews a nd statements relevant to this topic have described the status of allergic bronchopulmonary aspergil losis (ABPA) in cystic fibrosis [3], lower airways interaction with fungi and its clini cal consequences [4] and the whole topic of ABPA [5], the last with recommendations for a new definition…”
BackgroundSelf-citationHuman dectin-1 deficiency and mucocutaneous fungal infections
Ferwerda, B., Ferwerda, G., Plantinga, T. S., Willment, J. A., van Spriel, A. B., Venselaar, H., Elbers, C. C., Johnson, M. D., Cambi, A., Huysamen, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901053 · Cited by 752 · cited 1×
“The pathophysiological and clinical disease relevance of these receptors is corroborated by the finding that genetic mutations in distinct CLRs, namely dectin-1 [144] and CARD9 [145], cause CMC and other fungal infections.”
BackgroundHoward, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750
Self-citationO'Hollaren, M. T., Yunginger, J. W., Offord, K. P., Somers, M. J., O'Connell, E. J., Ballard, D. J., & Sachs, M. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240602 · Cited by 694 · cited 2×
“In contrast, some studies have shown that sensitization to fungi per se is a risk factor for admission to an intensive care unit with an acute attack of asthma [78] and respiratory arrest [79].”
BackgroundResultSTAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
van de Veerdonk, F. L., Plantinga, T. S., Hoischen, A., Smeekens, S. P., Joosten, L. A. B., Gilissen, C., Arts, P., Rosentul, D. C., Carmichael, A. J., Smits-van der Graaf, C. A. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100102 · Cited by 666
Denning, D. W., Riniotis, K., Dobrashian, R., & Sambatakou, H. (2003) · Clinical Infectious Diseases · doi:10.1086/376526 · Cited by 554 · cited 1×
“One of these is overlapping syndromes: separation of ABPA from Hyper IgE Syndrome (Job’s syndr ome) [21], separation of ABPA complicated by bronchiectasis and Aspergillus bronchitis [22], separation of ABPA from chronic pulmonary aspergillosis with a pr ominent TH2 response, including raised serum total and sIgE [23],…”
BackgroundSelf-citationDefective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
Romani, L., Fallarino, F., De Luca, A., Montagnoli, C., D’Angelo, C., Zelante, T., Vacca, C., Bistoni, F., Fioretti, M. C., Grohmann, U., et al. (2008) · Nature · doi:10.1038/nature06471 · Cited by 535 · cited 1×
“On the other hand, dysregulation of these pathways can drive exagger ated inflammatory responses/hyperinflammation as demonstrated in chr oni granulomatous disease (CGD) in mice [134].”
BackgroundA Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis
Stevens, D. A., Schwartz, H. J., Lee, J. Y., Moskovitz, B. L., Jerome, D. C., Catanzaro, A., Bamberger, D. M., Weinmann, A. J., Tuazon, C. U., Judson, M. A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003163421102 · Cited by 533 · cited 1×
“Two randomized placebo-control led studies which enrolled a total of 84 patients both demonstrated benefit compared with placebo [201,202].”
The Spectrum of Fungal Allergy
Simon-Nobbe, B., Denk, U., Pöll, V., Rid, R., & Breitenbach, M. (2008) · International Archives of Allergy and Immunology · doi:10.1159/000107578 · Cited by 524 · cited 1×
“Inter-strain variability leads to extracts with altered protein composition, resulting in poorly standardised allergy testing solutions [162].”
BackgroundEffect of insulating existing houses on health inequality: cluster randomised study in the community
Howden-Chapman, P., Matheson, A., Crane, J., Viggers, H., Cunningham, M., Blakely, T., Cunningham, C., Woodward, A., Saville-Smith, K., O'Dea, D., et al. (2007) · BMJ · doi:10.1136/bmj.39070.573032.80 · Cited by 521 · cited 3×
“Several interventional studies employing remediation of damp buildings [177], removing visible mould [178], removing water damaged materials [179-181], applyin g fu gicides [178], making alterations to heating [182], improving ventilation [178] and fix ing buildings construction to prevent further water leakage [183]…”
BackgroundMethodDenning, D. W., Pleuvry, A., & Cole, D. C. (2013) · Medical Mycology · doi:10.3109/13693786.2012.738312 · Cited by 495 · cited 3×
“8 million adults with ABPA complicating asthma [65].”
BackgroundMethodInfluentialSelf-citationFungi and allergic lower respiratory tract diseases
Knutsen, A. P., Bush, R. K., Demain, J. G., Denning, D. W., Dixit, A., Fairs, A., Greenberger, P. A., Kariuki, B., Kita, H., Kurup, V. P., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.12.970 · Cited by 482 · cited 5×
“The majority of SPT positive individuals are also positive by specific IgE, giving the SPT a high negative predictive value (95%); however a significant proportion of individuals with positive IgE tests are SPT negative [4].”
BackgroundInfluentialSelf-citationFungal rhinosinusitis: A categorization and definitional schema addressing current controversies
Chakrabarti, A., Denning, D. W., Ferguson, B. J., Ponikau, J., Buzina, W., Kita, H., Marple, B., Panda, N., Vlaminck, S., Kauffmann‐Lacroix, C., et al. (2009) · The Laryngoscope · doi:10.1002/lary.20520 · Cited by 481 · cited 1×
“Fungal sensitisation is also found in allergic rhinosinusitis, without asthma or ABPA, and is a diagnostic criterion for allergic Aspergillus rhinosinusitis [31,32].”
Self-citationAllergic bronchopulmonary aspergillosis
Greenberger, P. A. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.130179 · Cited by 476
C-type lectin receptors orchestrate antifungal immunity
Hardison, S. E., & Brown, G. D. (2012) · Nature Immunology · doi:10.1038/ni.2369 · Cited by 460 · cited 1×
“These CLR receptors have in common that they are coupled to Syk, which enables signaling via CARD9 and subsequent NFκB downstream activation [141].”
BackgroundDamp housing, mould growth, and symptomatic health state.
Platt, S. D., Martin, C. J., Hunt, S. M., & Lewis, C. W. (1989) · BMJ · doi:10.1136/bmj.298.6689.1673 · Cited by 457 · cited 1×
“Several studies have shown no association between visible indoor moulds or airborne moulds and bronchial hyperresponsiveness [93,94].”
BackgroundToll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation
Bochud, P.-Y., Chien, J. W., Marr, K. A., Leisenring, W. M., Upton, A., Janer, M., Rodrigues, S. D., Li, S., Hansen, J. A., Zhao, L. P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802629 · Cited by 453 · cited 1×
“Cellular studies are supported by genetic association studies showing that one TLR4 polymorphism is weakly linked to susceptibility for invasive aspergillosis following haematopoetic stem-cell transplantation [151,152].”
BackgroundUnderlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
Smith, N. L., & Denning, D. W. (2011) · European Respiratory Journal · doi:10.1183/09031936.00054810 · Cited by 449 · cited 4×
“9%) out of 126 CPA cases, some with aspergillomas [51].”
BackgroundInfluentialSelf-citationPneumocystis carinii Infection: Evidence for High Prevalence in Normal and Immunosuppressed Children
Pifer, L. L., Hughes, W. T., Stagno, S., & Woods, D. (1978) · Pediatrics · doi:10.1542/peds.61.1.35 · Cited by 434 · cited 1×
“Very early life airborne contact with fungi is well demonstrated by studies with Pneumocystis serology and pneumonia in healthy children and those with cancer [6].”
BackgroundFittipaldi, M., Nocker, A., & Codony, F. (2012) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2012.08.007 · Cited by 425 · cited 1×
“One approach that may circumvent this is viable-PCR (v-PCR), which utilises propidium monoazide (PMA) to detect only viable cells [109].”
BackgroundInnate Antifungal Immunity: The Key Role of Phagocytes
Brown, G. D. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101229 · Cited by 419 · cited 1×
“Macrophages phagocytose fungi, neutrophils phagocytose and/ or release their granule contents and form DNA neutrophil extracellular traps (NETs) to entangle, immobilize and kill the fungus, a process involving neutrophilderived calprotectin [118,119].”
BackgroundStern, D. A., Morgan, W. J., Halonen, M., Wright, A. L., & Martinez, F. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61447-6 · Cited by 418
Allergic Bronchopulmonary Aspergillosis
Agarwal, R. (2009) · Chest · doi:10.1378/chest.08-2586 · Cited by 407
Charlson, E. S., Diamond, J. M., Bittinger, K., Fitzgerald, A. S., Yadav, A., Haas, A. R., Bushman, F. D., & Collman, R. G. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0693oc · Cited by 348 · cited 1×
“These regions have been the target of the few published lung fungal microbiota studies [104,106,107].”
BackgroundDelhaes, L., Monchy, S., Fréalle, E., Hubans, C., Salleron, J., Leroy, S., Prevotat, A., Wallet, F., Wallaert, B., Dei-Cas, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036313 · Cited by 347 · cited 2×
“The internal transcribed spacer regions (ITS1 and ITS2) of the nuclear ribosomal operon are the most popular loci used to identify and discriminate between fungal species and reference databases have been developed to allow comparison and identification of amplicons [104,105].”
BackgroundDenning, D. W., O'Driscoll, B. R., Powell, G., Chew, F., Atherton, G. T., Vyas, A., Miles, J., Morris, J., & Niven, R. M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200805-737oc · Cited by 343 · cited 4×
“A broader approach was subsequently trialled using the wider spectrum agent itraconazole in SAFS patients sensitized to one or more of 7 fungi [27].”
BackgroundMethodInfluentialSelf-citationAzole antifungal resistance in Aspergillus fumigatus: 2008 and 2009
Bueid, A., Howard, S. J., Moore, C. B., Richardson, M. D., Harrison, E., Bowyer, P., & Denning, D. W. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq279 · Cited by 338
Self-citationThe medical effects of mold exposure
Bush, R. K., Portnoy, J. M., Saxon, A., Terr, A. I., & Wood, R. A. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.001 · Cited by 337 · cited 2×
“The European Academy of Allergy and Clinical Immunology (EAACI) Asthma Section decided to address this deficiency by forming a Task Force to address ‘Fungal Allergy in Asthma’.”
BackgroundAsthmatic symptoms and volatile organic compounds, formaldehyde, and carbon dioxide in dwellings.
Norbäck, D., Björnsson, E., Janson, C., Widström, J., & Boman, G. (1995) · Occupational and Environmental Medicine · doi:10.1136/oem.52.6.388 · Cited by 331 · cited 1×
“Several studies have shown no association between visible indoor moulds or airborne moul ds and bronchial hyperresponsiveness [93,94].”
BackgroundAllergic Bronchopulmonary Aspergillosis: Staging as an Aid to Management
PATTERSON, R., GREENBERGER, P. A., RADIN, R. C., & ROBERTS, M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-3-286 · Cited by 327 · cited 1×
“described five non-sequential stages of ABPA (acute, remission, exacerbation, steroid-dependent asthma and fibrosis) based on clinical presentation, including recurrent and/or chronic persistent symptoms [47,48].”
BackgroundMutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome
Woellner, C., Gertz, E. M., Schäffer, A. A., Lagos, M., Perro, M., Glocker, E.-O., Pietrogrande, M. C., Cossu, F., Franco, J. L., Matamoros, N., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.059 · Cited by 316 · cited 1×
“One of these is overlapping syndromes: separation of ABPA from Hyper IgE Syndrome (Job’s syndr ome) [21], separation of ABPA complicated by bronchiectasis and Aspergillus bronchitis [22], separation of ABPA from chronic pulmonary aspergillosis with a pr ominent TH2 response, including raised serum total and sIgE [23],…”
BackgroundEpidemic asthma and the role of the fungal mold Alternaria alternata
Pulimood, T. B., Corden, J. M., Bryden, C., Sharples, L., & Nasser, S. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.045 · Cited by 315 · cited 1×
“alternata in asthmatic subjects with grass pollen sensitivity was found to predict susceptibility to thunderstorm-associated asthma [81].”
BackgroundDenning, D. W., Park, S., Lass-Florl, C., Fraczek, M. G., Kirwan, M., Gore, R., Smith, J., Bueid, A., Moore, C. B., Bowyer, P., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir179 · Cited by 313 · cited 1×
“PCR has been proposed as an alternative or a dditional approach to detecting Aspergillus species in sputum and has been shown to be more sensitive than culture in ABPA but needs to be interpreted with other clinical and laboratory features [174].”
BackgroundSelf-citationSensitivity to fungal allergens is a risk factor for life‐threatening asthma
Black, P. N., Udy, A. A., & Brodie, S. M. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00293.x · Cited by 305 · cited 1×
“In contrast, s ome studies have shown that sensitization to fungi per se is a risk factor for admission to an intensive care unit with an acute attack of asthma [78] and respiratory arrest [79].”
ResultWark, P. A. B., Hensley, M. J., Saltos, N., Boyle, M. J., Toneguzzi, R. C., Epid, G. D. C., Simpson, J. L., McElduff, P., & Gibson, P. G. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1388 · Cited by 298 · cited 1×
“Two randomized placebo-controlled studies which enrolled a total of 84 patients both demonstrated benefit compared with placebo [201,202].”
BackgroundZock, J.-P., Jarvis, D., Luczynska, C., Sunyer, J., & Burney, P. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.126383 · Cited by 269
Particle-size distributions and seasonal diversity of allergenic and pathogenic fungi in outdoor air
Yamamoto, N., Bibby, K., Qian, J., Hospodsky, D., Rismani-Yazdi, H., Nazaroff, W. W., & Peccia, J. (2012) · The ISME Journal · doi:10.1038/ismej.2012.30 · Cited by 266 · cited 1×
“7% of total fungal taxa [75].”
Gergen, P. J., & Turkeltaub, P. C. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90130-t · Cited by 257 · cited 1×
“Subjects s ensitized to moulds, particularly to Cladosporium and Alternaria are at significantly higher risk of current asthma if they reported mould exposure [86,87,89].”
BackgroundPolymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis
Carvalho, A., Pasqualotto, A. C., Pitzurra, L., Romani, L., Denning, D. W., & Rodrigues, F. (2008) · The Journal of Infectious Diseases · doi:10.1086/526500 · Cited by 255 · cited 3×
“This issue needs resolution, possibly by genotyping patients wi th different forms of asthma [30], if genotypes allow such classifications, which they may not.”
BackgroundSelf-citationExposure to Alternaria alternata in US homes is associated with asthma symptoms
Salo, P. M., Arbes, S. J., Sever, M., Jaramillo, R., Cohn, R. D., London, S. J., & Zeldin, D. C. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.07.037 · Cited by 255 · cited 1×
“Prevalence of current symptomati c asthma and use of asthma medications increase significantly with higher Alt naria alternata allergen levels indoor [90].”
BackgroundIgE Sensitization to Aspergillus fumigatus Is Associated with Reduced Lung Function in Asthma
Fairs, A., Agbetile, J., Hargadon, B., Bourne, M., Monteiro, W. R., Brightling, C. E., Bradding, P., Green, R. H., Mutalithas, K., Desai, D., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0087oc · Cited by 252 · cited 3×
“Importantly, these patients have impaired lung function and increased rates of bronchiectasis compared to matched controls suggesting evidence of tissue damage [24].”
BackgroundInfluentialSelf-citationMcKenzie, C. G. J., Koser, U., Lewis, L. E., Bain, J. M., Mora-Montes, H. M., Barker, R. N., Gow, N. A. R., & Erwig, L. P. (2010) · Infection and Immunity · doi:10.1128/iai.00001-10 · Cited by 250 · cited 1×
“However, some fungi are capable of evading these host defense me chanisms, for instance Candida, by affecting phagosome maturation and phagosomal escape by forma tion of hyphae that destroy the vesicle and subsequently the entire host cell [121,122].”
BackgroundTLRs Govern Neutrophil Activity in Aspergillosis
Bellocchio, S., Moretti, S., Perruccio, K., Fallarino, F., Bozza, S., Montagnoli, C., Mosci, P., Lipford, G. B., Pitzurra, L., & Romani, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7406 · Cited by 242
Adverse Human Health Effects Associated with Molds in the Indoor Environment
&NA; (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200305000-00006 · Cited by 237 · cited 2×
“Available statements from different medical associations are unequivocal in declaring that fungi are sensitizers and exacerbate allergic asthma (American College of Occupational and Environmental Medicine [1], Institute of Medicine, American Academy of Allergy, Asthma and Clinical Immunology [2] and American College o…”
BackgroundAllergic Bronchopulmonary Aspergillosis
Agarwal, R., Gupta, D., Aggarwal, A. N., Behera, D., & Jindal, S. K. (2006) · Chest · doi:10.1378/chest.130.2.442 · Cited by 234 · cited 2×
“In a study of 126 patients, the clinical, spirometric and immunologic findings were not significantly different when classified in terms of either ABPA-S and ABPA-CB or ABPA-S, ABPA-CB and ABPACB-ORF [57].”
BackgroundResultAgarwal, R., Gupta, D., Aggarwal, A. N., Saxena, A. K., Chakrabarti, A., & Jindal, S. K. (2007) · Chest · doi:10.1378/chest.07-0808 · Cited by 228 · cited 7×
“High-attenuation mucus (HAM) is a characteristic radiologic finding seen in patients with ABPA [57], and not in any other asthma entity.”
BackgroundInfluentialMolecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients
Bittar, F., Richet, H., Dubus, J.-C., Reynaud-Gaubert, M., Stremler, N., Sarles, J., Raoult, D., & Rolain, J.-M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002908 · Cited by 224 · cited 1×
“The application of sequence-based identification and metagenomics to st udies of the human microbiome has revealed a plethora of organisms that can inhabit the human body including new or as yet unknown pathogens [100-102].”
BackgroundThe relation between fungal propagules in indoor air and home characteristics
Ren, P., Jankun, T. M., Belanger, K., Bracken, M. B., & Leaderer, B. P. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.056005419.x · Cited by 223 · cited 1×
“Indoor Moulds are commonly present in houses; a study evaluating the presence of different mould species in more than 1000 houses in Northeast USA revealed that Cladosporium spp is found in 85%, Penicillium, Aspergillus and Alternaria respectively in 75%, 50% and 28% of homes [85].”
BackgroundSeider, K., Brunke, S., Schild, L., Jablonowski, N., Wilson, D., Majer, O., Barz, D., Haas, A., Kuchler, K., Schaller, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003730 · Cited by 220 · cited 1×
“However, some fungi are capable of evading these host defense me chanisms, for instance Candida, by affecting phagosome maturation and phagosomal escape by forma tion of hyphae that destroy the vesicle and subsequently the entire host cell [121,122].”
BackgroundAllergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview
Chowdhary, A., Agarwal, K., Kathuria, S., Gaur, S. N., Randhawa, H. S., & Meis, J. F. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.754401 · Cited by 220 · cited 2×
“It has been recognised that other fungi can induce a disease process similar to ABPA, normally called allergic bronchopulmonary mycosis (ABPM) [25].”
BackgroundNovel immunologic classification of aspergillosis in adult cystic fibrosis
Baxter, C. G., Dunn, G., Jones, A. M., Webb, K., Gore, R., Richardson, M. D., & Denning, D. W. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.007 · Cited by 215 · cited 1×
“cutoff of >180 IU/mL was 91% sensitive and 90% specific [18] in contras t o an Indian cohort of asthmatic patients with ABPA in whom a total serum IgE of 2346 IU/mL (sensitivity 87.”
BackgroundSelf-citationAllergic broncho‐pulmonary aspergillosis: Clinical immunology: (1) Clinical features
McCARTHY, D. S., & PEPYS, J. (1971) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1971.tb00779.x · Cited by 215
Work Is Related to a Substantial Portion of Adult-onset Asthma Incidence in the Finnish Population
KARJALAINEN, A., KURPPA, K., MARTIKAINEN, R., KLAUKKA, T., & KARJALAINEN, J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2012146 · Cited by 213 · cited 1×
“The fraction of adulthood asthma incidence attributable to work is about 30% [69].”
BackgroundAllergic Bronchopulmonary Aspergillosis in Asthma and Cystic Fibrosis
Knutsen, A. P., & Slavin, R. G. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/843763 · Cited by 209 · cited 1×
“The skin-prick test (SPT) is a simple diagnostic tool that can be useful for screening for ABPA [161], but it is not without limitations.”
BackgroundReported incidence of occupational asthma in the United Kingdom, 1989–97
McDonald, J. C., Keynes, H. L., & Meredith, S. K. (2000) · Occupational and Environmental Medicine · doi:10.1136/oem.57.12.823 · Cited by 209 · cited 1×
“The same increasing trends have been shown in UK [72].”
BackgroundKESH, S., MENSAH, N. Y., PETERLONGO, P., JAFFE, D., HSU, K., VAN DEN BRINK, M., O'REILLY, R., PAMER, E., SATAGOPAN, J., & PAPANICOLAOU, G. A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1358.012 · Cited by 208
Damp housing and asthma: a case-control study
Williamson, I. J., Martin, C. J., McGill, G., Monie, R. D., & Fennerty, A. G. (1997) · Thorax · doi:10.1136/thx.52.3.229 · Cited by 207
Infant origins of childhood asthma associated with specific molds
Reponen, T., Lockey, J., Bernstein, D. I., Vesper, S. J., Levin, L., Khurana Hershey, G. K., Zheng, S., Ryan, P., Grinshpun, S. A., Villareal, M., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.05.030 · Cited by 202 · cited 1×
“Many recent studies describe mould-related respiratory effects in asthma [66-68].”
BackgroundSelected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA
Kurup, Banerjee, Hemmann, Greenberger, Blaser, & Crameri (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00837.x · Cited by 196 · cited 1×
“fumigatus allergens have been evaluated for their diagnostic performance in serologic studies in asthmatic patients [164], and data suggests they may be useful in discriminating between ABPA (Asp f 2, Asp f 4 and Asp f 6) and fungal allergy (Asp f 1 and Asp f 3) [165,166].”
BackgroundThe eXpeRience registry: The ‘real-world’ effectiveness of omalizumab in allergic asthma
Braunstahl, G.-J., Chen, C.-W., Maykut, R., Georgiou, P., Peachey, G., & Bruce, J. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.04.017 · Cited by 196 · cited 1×
“While a recent study indicates that omalizumab is associated with improvements in outcomes in patients with uncontrolled persistent allergic asthma [195], the very high IgE in ABPA makes the use of omaluzimab difficult because of cost and administration limitations (volume).”
BackgroundThe effect of outdoor fungal spore concentrations on daily asthma severity.
Delfino, R. J., Zeiger, R. S., Seltzer, J. M., Street, D. H., Matteucci, R. M., Anderson, P. R., & Koutrakis, P. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105622 · Cited by 191 · cited 1×
“Delfino and coworkers found associations between fungal spore concentrat ions, particularly Alternaria and Helminthosporium, and increased asthma symptom scores, decreased evening PEF and β-agonist inhaler use in adult asthmatics sensitized to fungi [80].”
BackgroundAgarwal, R., Aggarwal, A. N., Gupta, D., & Jindal, S. K. (2009) · PubMed · Cited by 191
Allergic bronchopulmonary aspergillosis
Tillie‐Leblond, I., & Tonnel, A. ‐. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00887.x · Cited by 189
The innate immune response to Aspergillus fumigatus
Balloy, V., & Chignard, M. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.07.002 · Cited by 188 · cited 1×
“fumigatus invasion and are essential in restraining tissue invasion and fungal spreading from the airways into the bloodstream [123,124].”
BackgroundAntigenic Analysis of Household Dust Samples
Wood, R. A., Eggleston, P. A., Lind, P., Ingemann, L., Schwartz, B., Graveson, S., Terry, D., Wheeler, B., & Adkinson, N. F. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.2.358 · Cited by 187 · cited 1×
“Wood and coworkers [92] did not find association between indoor mould and positive skin tests for common moulds.”
BackgroundKellett, F., Redfern, J., & McL Niven, R. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2004.05.006 · Cited by 178 · cited 1×
“Nebulized hypertonic saline (6-7%, 4-5 mL) can be used to reduce the vis cosity of sputum to ease expectoration of mucus plugs encountered in ABPA [199].”
Methodvan Woerden, H. C., Gregory, C., Brown, R., Marchesi, J. R., Hoogendoorn, B., & Matthews, I. P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-69 · Cited by 177
Análisis farmacoeconómico de la pentoxifilina en úlceras venosas
Marinel·lo-Roura, J., Iglesias-García, C., Lorenzo-Ferrer, J., Mercadal-Dalmau, J., & Lozano-Fernández de Pinedo, R. (2007) · Angiología · doi:10.1016/s0003-3170(07)75026-5 · Cited by 174
Agarwal, R., Maskey, D., Aggarwal, A. N., Saikia, B., Garg, M., Gupta, D., & Chakrabarti, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061105 · Cited by 174 · cited 5×
“The utility of the Patterson criteria have been prospectively evaluated and compared with recently introduced criteria by Agarwal [19].”
BackgroundMethodInfluentialRespiratory allergy to Aspergillus-derived enzymes in bakers' asthma
Quirce, S., Cuevas, M., Díez-Gómez, M. L., Fernández-Rivas, M., Hinojosa, M., González, R., & Losada, E. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90470-m · Cited by 173 · cited 1×
“One of the most well established causes of occupational asthma associated with fungal allergens is alpha amylase from Aspergillus oryzae which is used as a additive in bakeries and can lead to ‘bakers asthma’ [73].”
BackgroundRecognition of fungal pathogens by Toll-like receptors
Netea, M. G., Graaf, C., Meer, J. W. M., & Kullberg, B. J. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1192-7 · Cited by 171 · cited 1×
“The MyD88 -coupled TLRs TLR1, TLR2, TLR4, TLR6 and TLR9 have been reported to contribute to fungal recognition in different experimental systems, with TLR2, TLR4 and TLR6 probabl y being the most important ones [147-150].”
BackgroundPatterson, R. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360170130020 · Cited by 169 · cited 1×
“described five non-sequential stages of ABPA (acute, remission, exacerbation, steroid-dependent asthma and fibrosis) based on clinical presentation, including recurrent and/or chronic persistent symptoms [47,48].”
BackgroundO'Driscoll, B. R., Powell, G., Chew, F., Niven, R. M., Miles, J. F., Vyas, A., & Denning, D. W. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03339.x · Cited by 166
Self-citationAllergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma
Greenberger, P. A., & Patterson, R. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)91034-2 · Cited by 166 · cited 1×
“ABPA was first described in 1952 [13], and the criteria for diagnosis were defined during the 1970s and 1980s [14-17].”
BackgroundAllergen detection from 11 fungal species before and after germination
Green, B. J., Zinovia Mitakakis, T., & Tovey, E. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.57 · Cited by 162 · cited 1×
“Our supposition is that fungal airway infection induces an ongoing allergic stimulus, as although most fungal conidia (spores) release some allergen(s), many more are produced after spore swelling and germination [36]; before germination the conidia are covered in hydrophobin proteins, which elicit no immune reaction…”
BackgroundAspergillus fumigatus during stable state and exacerbations of COPD
Bafadhel, M., Mckenna, S., Agbetile, J., Fairs, A., Desai, D., Mistry, V., Morley, J. P., Pancholi, M., Pavord, I. D., Wardlaw, A. J., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00162912 · Cited by 161 · cited 1×
“fumigatus and this was associated with worse pulmonary function [33].”
BackgroundSelf-citationMenzies, D., Holmes, L., McCumesky, G., Prys-Picard, C., & Niven, R. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02542.x · Cited by 160 · cited 1×
“fumigatus have a much higher rate of bronchiectasis [34], and children sensitised to Alternaria are more likely to have persistent asthma in adulthood [35].”
BackgroundThe definition and diagnosis of Asthma
Hargreave, F. E., & Nair, P. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03321.x · Cited by 159
Allergic broncho‐pulmonary aspergillosis Clinical immunology: (2) Skin, nasal and bronchial tests
McCARTHY, D. S., & PEPYS, J. (1971) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1971.tb00793.x · Cited by 154 · cited 1×
“ABPA was first described in 1952 [13], and the criteria for diagnosis were defined during the 1970s and 1980s [14-17].”
BackgroundShortt, N., & Rugkåsa, J. (2005) · Health & Place · doi:10.1016/j.healthplace.2005.10.004 · Cited by 151 · cited 3×
“materials [179-181], applying fungicides [178], making alterations to heating [182], improving ventilation [178] and fixing buildings construction to prevent further water leakage [183] have been conducted.”
BackgroundReponen, T., Vesper, S., Levin, L., Johansson, E., Ryan, P., Burkle, J., Grinshpun, S. A., Zheng, S., Bernstein, D. I., Lockey, J., et al. (2011) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2011.04.018 · Cited by 151 · cited 1×
“Many recent studies describe mould-related respiratory effect s in asthma [66-68].”
BackgroundAllergic fungal sinusitis: pathophysiology, diagnosis and management
Schubert, M. S. (2009) · Medical Mycology · doi:10.1080/13693780802314809 · Cited by 151 · cited 1×
“Fungal sensitisation is also found in allergic rhinosinusitis, without asthma or ABPA, and is a diagnostic criterion for allergic Aspergillus rhinosinusitis [31,32].”
BackgroundChishimba, L., Niven, R. M., Cooley, J., & Denning, D. W. (2012) · Journal of Asthma · doi:10.3109/02770903.2012.662568 · Cited by 148 · cited 2×
“Asthma severity may also change with antifungal therapy, which was vividly illustrated by a report of antifungal therapy allowing one third of patients having their asthma severity downgraded [29].”
BackgroundSelf-citationFungal fragments and undocumented conidia function as new aeroallergen sources
Green, B. J., Sercombe, J. K., & Tovey, E. R. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.009 · Cited by 148 · cited 1×
“Preformed allergen from hyphal fragments may elicit an immune response, even in the absence of local germination and growth [38], possibly explaining why increased environmental exposure to Cladosporium spp.”
Background113 Bronchoalveolar lavage in allergic bronchopulmonary aspergillosis (ABPA)
Greenberger, P., Smith, L. J., Roberts, M. S., & Liotta, J. L. (1985) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(85)90248-9 · Cited by 145
Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis
Crameri, R. (1998) · International Immunology · doi:10.1093/intimm/10.8.1211 · Cited by 145 · cited 1×
“asthmatic patients [164], and data suggests they may be useful i n discriminating between ABPA (Asp f 2, Asp f 4 and Asp f 6) and fungal allergy (Asp f 1 and Asp f 3) [165,166].”
BackgroundSahrbacher, U. C., Lechner, F., Eugster, H.-P., Frei, K., Lassmann, H., & Fontana, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199804)28:04<1332::aid-immu1332>3.0.co;2-g · Cited by 144
Sauni, R., Verbeek, J. H. A. M., Uitti, J. A., Jauhiainen, M., Kreiss, K., & Sigsgaard, T. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007897.pub3 · Cited by 143 · cited 1×
“Several interventional studies employing remediation of damp buildings [177], removing visible mould [178], removing water damaged materials [179-181], applyin g fu gicides [178], making alterations to heating [182], improving ventilation [178] and fix ing buildings construction to prevent further water leakage [183]…”
BackgroundRecognition of Fungal Pathogens by Toll-Like Receptors
Netea, M., Ferwerda, G., van der Graaf, C., Van der Meer, J. W., & Kullberg, B. J. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778743538 · Cited by 143
Current Concepts of Hyperinflammation in Chronic Granulomatous Disease
Rieber, N., Hector, A., Kuijpers, T., Roos, D., & Hartl, D. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/252460 · Cited by 141 · cited 1×
“These studies also show that the indoleamine 2,3-dioxygenase (IDO), a key enzyme of tryptophan metabolism, is involved in CGD-associated inflammation and tryptophan catabolites (kynurenines) could be therapeutically useful to regulate and dampen hyperinflammation [135,136] although the regulation of this pathway in hu…”
BackgroundSelf-citationCurrent asthma and biochemical signs of inflammation in relation to building dampness in dwellings.
Norbäck, D., Bjornsson, E. H., Janson, C., Palmgren, U., & Boman, G. (1999) · PubMed · Cited by 137
Childhood asthma epidemiology: Insights from comparative studies of rural and urban populations
Wong, G. W. K., & Chow, C. M. (2008) · Pediatric Pulmonology · doi:10.1002/ppul.20755 · Cited by 134
Hemmann, S., Nikolaizik, W. H., Schöni, M. H., Blaser, K., & Crameri, R. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199804)28:04<1155::aid-immu1155>3.0.co;2-6 · Cited by 133 · cited 1×
“asthmatic patients [164], and data suggests they may be useful i n discriminating between ABPA (Asp f 2, Asp f 4 and Asp f 6) and fungal allergy (Asp f 1 and Asp f 3) [165,166].”
BackgroundAllergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis.
Greenberger, P. A., Miller, T. P., Roberts, M., & Smith, L. J. (1993) · PubMed · Cited by 132
Reference databases for taxonomic assignment in metagenomics
Santamaria, M., Fosso, B., Consiglio, A., De Caro, G., Grillo, G., Licciulli, F., Liuni, S., Marzano, M., Alonso-Alemany, D., Valiente, G., et al. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbs036 · Cited by 129 · cited 1×
“The internal transcribed spacer regions (ITS1 and ITS2) of the nuclear ribosomal operon are the most popular loci used to identify and discriminate between fungal species and reference databases have been developed to allow comparison and identification of amplicons [104,105].”
BackgroundBouzani, M., Ok, M., McCormick, A., Ebel, F., Kurzai, O., Morton, C. O., Einsele, H., & Loeffler, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003593 · Cited by 127 · cited 1×
“Even NK cells were recently found to potently fight Aspergillus fumigatus [120].”
BackgroundMechanisms controlling Th17 cytokine expression and host defense
McAleer, J. P., & Kolls, J. K. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0211099 · Cited by 125 · cited 1×
“Among cells of adaptive immune system, particularly IL-17-secreting T-helper cells (Th17) play a key role in anti-fungal host defense [129,130].”
BackgroundC-type lectin receptors and cytokines in fungal immunity
Vautier, S., MacCallum, D. M., & Brown, G. D. (2011) · Cytokine · doi:10.1016/j.cyto.2011.08.031 · Cited by 123 · cited 1×
“For immune homeostasis it is critical to prevent excess inflammation and tissue damage in response to harmless species [112,113].”
BackgroundHydrophilic Fungi and Ergosterol Associated with Respiratory Illness in a Water-Damaged Building
Park, J., Cox‐Ganser, J. M., Kreiss, K., White, S., & Rao, C. Y. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10355 · Cited by 121 · cited 1×
“Adult-onset asthma is strongly associated with the l evel of fungal exposure [70].”
BackgroundInfluence of Interleukin‐10 on Aspergillus fumigatus Infection in Patients with Cystic Fibrosis
Brouard, J., Knauer, N., Boelle, P., Corvol, H., Henrion‐Caude, A., Flamant, C., Bremont, F., Delaisi, B., Duhamel, J., Marguet, C., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429964 · Cited by 120 · cited 2×
“The genes implicated to date include IL-4Rα [153,154], IL-10 [155], surfactant A2 (SPA2) [156], TLR9 [30], CFTR [157-159], and HLA DR2/DR5 polymorphisms [160].”
BackgroundEffects on patients with asthma of eradicating visible indoor mould: a randomised controlled trial
Burr, M. L., Matthews, I. P., Arthur, R. A., Watson, H. L., Gregory, C. J., Dunstan, F. D. J., & Palmer, S. R. (2007) · Thorax · doi:10.1136/thx.2006.070847 · Cited by 118 · cited 5×
“Several interventional studies employing remediation of damp buildings [177], removing visible mould [178], removing water damaged materials [179-181], applyin g fu gicides [178], making alterations to heating [182], improving ventilation [178] and fix ing buildings construction to prevent further water leakage [183]…”
BackgroundMethodInfluentialIL-17 and Therapeutic Kynurenines in Pathogenic Inflammation to Fungi
Romani, L., Zelante, T., De Luca, A., Fallarino, F., & Puccetti, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5157 · Cited by 117
Are atopy and specific IgE to mites and molds important for adult asthma?
Jaakkola, M. S., Ieromnimon, A., & Jaakkola, J. J. K. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.11.003 · Cited by 116 · cited 1×
“herbarum [95].”
Pashley, C. H., Fairs, A., Morley, J. P., Tailor, S., Agbetile, J., Bafadhel, M., Brightling, C. E., & Wardlaw, A. J. (2012) · Medical Mycology · doi:10.3109/13693786.2011.615762 · Cited by 116 · cited 2×
“The st andard approach used to process sputum for mycological investigations in the UK has been shown to potentially underestimate fungal prevalence in the airway [170], and a recent mul ti-centre study has highlighted the variability in culture results that arise from di fferent mycological methods being employed [17…”
BackgroundMethodSelf-citationSensing of mammalian IL-17A regulates fungal adaptation and virulence
Zelante, T., Iannitti, R. G., LUCA, A. D., Arroyo, J., Blanco, N., Servillo, G., Sanglard, D., Reichard, U., Palmer, G. E., Latgé, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1685 · Cited by 113 · cited 1×
“A recent study further shows that IL-17A itself is able to bind fungal cells, thereby causing nutrient starvation conditions [132].”
BackgroundAgbetile, J., Fairs, A., Desai, D., Hargadon, B., Bourne, M., Mutalithas, K., Edwards, R., Morley, J. P., Monteiro, W. R., Kulkarni, N. S., et al. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.03987.x · Cited by 113 · cited 2×
“Furthermore, living in damp dwellings per se is associated with current asthma, lower FEV1 [88] and higher PEF variability [87].”
BackgroundSelf-citationThe Effect of Aspergillus fumigatus Infection on Vitamin D Receptor Expression in Cystic Fibrosis
Coughlan, C. A., Chotirmall, S. H., Renwick, J. A. A., Hassan, T. M., Low, T. B., Bergsson, G., Eshwika, A., Bennett, K., Dunne, K., Greene, C. M., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0478oc · Cited by 112 · cited 1×
“A recent study examining the impact of itraconazole on Vitamin D receptor expression in CF patients suggests a prolonged effect of down-regulation, lasting significantly longer than itraconazole therapy, possibly indicati ng that after successful therapy a sustained effect may be found in some patients [210].”
BackgroundThe Damage-Response Framework of Microbial Pathogenesis and Infectious Diseases
Pirofski, L., & Casadevall, A. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-09550-9_11 · Cited by 111 · cited 1×
“Figure 1 Patterns of fungal interactions with humans, illustrating different host pathogen interactions, based on the host damage response framework [9].”
BackgroundVaid, M., Kaur, S., Sambatakou, H., Madan, T., Denning, D. W., & Sarma, P. U. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.033 · Cited by 111 · cited 1×
“The genes implicated to date include IL-4R α [153,154], IL-10 [155], surfactant A2 (SPA2) [156], TLR9 [30], CFTR [157-159], and HLA DR2/DR5 polymorphisms [160].”
BackgroundSelf-citationTRICHOPHYTON ASTHMA: SENSITISATION OF BRONCHI AND UPPER AIRWAYS TO DERMATOPHYTE ANTIGEN
Ward, G. W., Rose, G., Karlsson, G., & Platts-Mills, T. E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92863-8 · Cited by 110 · cited 1×
“There are multiple lines of evidence for sensitisation to Tricophyton proteins in asthma patients [39-42], where inhalation and/or dermal absorption of Trichophyton antigens are currently considered as possible routes of exposure [39,41].”
BackgroundReducing bias in bacterial community analysis of lower respiratory infections
Rogers, G. B., Cuthbertson, L., Hoffman, L. R., Wing, P. A. C., Pope, C., Hooftman, D. A. P., Lilley, A. K., Oliver, A., Carroll, M. P., Bruce, K. D., et al. (2013) · The ISME Journal · doi:10.1038/ismej.2012.145 · Cited by 107 · cited 1×
“In sputum samples from individuals w ith cystic fibrosis, comparison of PMA treated and untreated clinical samples indicated that dead bacterial cells significantly bias untreated profiles [110].”
BackgroundExposure to poultry dust and health effects in poultry workers: impact of mould and mite allergens
Rimac, D., Macan, J., Varnai, V. M., Vučemilo, M., Matković, K., Prester, L., Orct, T., Trošić, I., & Pavičić, I. (2009) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-009-0487-5 · Cited by 104 · cited 1×
“Specifically poultry farms may represent a local major source of fungi [187,188] and poultry workers have a higher rate of asthma [189,190] and mould IgG antibodies [189].”
BackgroundBorman, A. M., Palmer, M. D., Delhaès, L., Carrère, J., Favennec, L., Ranque, S., Gangneux, J., Horré, R., & Bouchara, J. (2010) · Medical Mycology · doi:10.3109/13693786.2010.511287 · Cited by 104 · cited 2×
“The standard approach used to process sputum for mycological investigations in the UK has been shown to potentially underestimate fungal prevalence in the airway [170], and a recent multi-centre study has highlighted the variability in culture results that arise from different mycological methods being employed [171].”
BackgroundMethodTaccetti, G., Bianchini, E., Cariani, L., Buzzetti, R., Costantini, D., Trevisan, F., Zavataro, L., & Campana, S. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200832 · Cited by 104 · cited 1×
“Newer approaches inc lude oral high dose ciprofloxacin combined with nebulized colistin, following the lead of the cystic fi brosis community [221].”
BackgroundAspergillus bronchitis without significant immunocompromise
Chrdle, A., Mustakim, S., Bright-Thomas, R. J., Baxter, C. G., Felton, T., & Denning, D. W. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06816.x · Cited by 101 · cited 1×
“One of these is overlapping syndromes: separation of ABPA from Hyper IgE Syndrome (Job’s syndrome) [21], separation of ABPA complicated by bronchiectasis and Aspergillus bronchitis [22], separation of ABPA from chronic pulmonary aspergillosis with a prominent TH2 response, including raised serum total and sIgE [23], a…”
BackgroundSelf-citationPashley, C. H., Fairs, A., Free, R. C., & Wardlaw, A. J. (2011) · Fungal Biology · doi:10.1016/j.funbio.2011.11.004 · Cited by 101 · cited 1×
“Host-pathogen interactions Neglect or react? Every day we breath 20,000 times, thereby inhaling ~10,000 liters of air, which during the fungal season can often contain >50,000 fungal spores per cubic meter of air per day [111].”
BackgroundSelf-citationTemporal associations between daily counts of fungal spores and asthma exacerbations
Atkinson, R. W., Strachan, D. P., Anderson, H. R., Hajat, S., & Emberlin, J. (2006) · Occupational and Environmental Medicine · doi:10.1136/oem.2005.024448 · Cited by 101 · cited 1×
“Several studies did not find associations of outdoor fungal spore counts and visits to emergency departments or hospital admissions due to asthma exacerbations in adults [76,77], although both studies did find these associations in children.”
BackgroundOutcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis
White, L., Mirrani, G., Grover, M., Rollason, J., Malin, A., & Suntharalingam, J. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.11.018 · Cited by 98 · cited 1×
“Some patients become infected and others colonised by Pseudomonas aeruginosa, usually those with bronchiectasis [218].”
BackgroundMarchand, É., Delaunois, L., Brancaleone, P., Vandenplas, O., Mairesse, M., Verellen‐Dumoulin, C., & Rahier, J. (2001) · CHEST Journal · doi:10.1378/chest.119.3.762 · Cited by 97 · cited 1×
“The genes implicated to date include IL-4R α [153,154], IL-10 [155], surfactant A2 (SPA2) [156], TLR9 [30], CFTR [157-159], and HLA DR2/DR5 polymorphisms [160].”
BackgroundMicrobial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing
Armougom, F., Bittar, F., Stremler, N., Rolain, J., Robert, C., Dubus, J. ‐., Sarles, J., Raoult, D., & Scola, B. L. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0749-x · Cited by 95 · cited 1×
“The application of sequence-based identification and metagenomics to st udies of the human microbiome has revealed a plethora of organisms that can inhabit the human body including new or as yet unknown pathogens [100-102].”
BackgroundTh17 cells in the setting of Aspergillus infection and pathology
Zelante, T., Bozza, S., De Luca, A., D'angelo, C., Bonifazi, P., Moretti, S., Giovannini, G., Bistoni, F., & Romani, L. (2009) · Medical Mycology · doi:10.1080/13693780802140766 · Cited by 94 · cited 1×
“The Th17 response works in concert with IL-22, IL-23 and Th1/ Tregs responses to control fungal dissemination [133].”
BackgroundChemokines Indicate Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis
Hartl, D., Latzin, P., Zissel, G., Krane, M., Krauss-Etschmann, S., & Griese, M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1271oc · Cited by 92 · cited 1×
“Clinically, CCL17 may serve as a serum biomarker in patients to differentiate sensitization to Aspergillus from clinically active ABPA flares, especially when quantified longitudinally, as supported by two studies [127,128]; cutoffs are not established.”
BackgroundSelf-citationTreatment of late-onset asthma with fluconazole
Ward, G. W., Woodfolk, J. A., Hayden, M. L., Jackson, S., & Platts‐Mills, T. A. E. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70321-0 · Cited by 91
Sauni, R., Uitti, J. A., Jauhiainen, M., Kreiss, K., Sigsgaard, T., & Verbeek, J. H. A. M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007897.pub2 · Cited by 89
Allergic Respiratory Disease and Fungal Remediation in a Building in a Subtropical Climate
Jarvis, J. Q., & Morey, P. R. (2001) · Applied Occupational and Environmental Hygiene · doi:10.1080/10473220117482 · Cited by 89 · cited 3×
“materials [179-181], applying fungicides [178], making alterations to heating [182], improving ventilation [178] and fixing buildings construction to prevent further water leakage [183] have been conducted.”
BackgroundAllergic Bronchopulmonary Aspergillosis and Related Allergic Syndromes
Hogan, C., & Denning, D. (2011) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0031-1295716 · Cited by 89 · cited 1×
“These fungi can both colonize and infect the airways not only upon systemic immunosuppression, but also in pulmonary diseases where the local mucosal host defense is compromised, such as allergic asthma and cystic fibrosis [4,114-117].”
BackgroundSelf-citationRogers, G. B., Marsh, P., Stressmann, F. A., Allen, C. E., Daniels, T. V., Carroll, M. P., & Bruce, K. D. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03189.x · Cited by 88 · cited 1×
“DNA-derived signals can originate from nonviable fungal cells [175,176] and therefore there is the potential for a positive PCR signal to derive from dead fungal material, particularly in the context of a patient who has been treated with antifungals.”
BackgroundAgbetile, J., Bourne, M., Fairs, A., Hargadon, B., Desai, D., Broad, C., Morley, J. P., Bradding, P., Brightling, C. E., Green, R. H., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.050 · Cited by 88 · cited 1×
“fumigatus [207].”
Self-citationAssessing the diagnostic importance of nonviable bacterial cells in respiratory infections
Rogers, G. B., Stressmann, F. A., Koller, G., Daniels, T. W. V., Carroll, M. P., & Bruce, K. D. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.06.011 · Cited by 86 · cited 1×
“DNA-derived signals can originate from nonviable fungal cells [175,176] and therefore there is the potential for a positive PCR signal to de rive from dead fungal material, particularly in the context of a patient who has been treated with antifungals.”
BackgroundFraczek, M. G., Kirwan, M., Moore, C. B., Morris, J., Denning, D. W., & Richardson, M. D. (2013) · Mycoses · doi:10.1111/myc.12103 · Cited by 86 · cited 1×
“As such a number of groups have questioned the performance of the current UK respiratory culture methods for fungi and have called out for an improved, standardised approach [170-173].”
BackgroundSelf-citationFungal and other spore counts as predictors of admissions for asthma in the Trent region
Newson, R., Strachan, D., Corden, J., & Millington, W. (2000) · Occupational and Environmental Medicine · doi:10.1136/oem.57.11.786 · Cited by 83 · cited 1×
“Several studies did not find associations of outdoor fungal spore counts and visits to emergency departments or hospital admissions due to asthma exacerbations in adults [76,77], although both studies did find these associations in children.”
BackgroundIL-4 alpha chain receptor (IL-4Rα) polymorphisms in allergic bronchopulmonary sspergillosis
Knutsen, A. P., Kariuki, B., Consolino, J. D., & Warrier, M. R. (2006) · Clinical and Molecular Allergy · doi:10.1186/1476-7961-4-3 · Cited by 83 · cited 1×
“The genes implicated to date include IL-4R α [153,154], IL-10 [155], surfactant A2 (SPA2) [156], TLR9 [30], CFTR [157-159], and HLA DR2/DR5 polymorphisms [160].”
BackgroundThe protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A
Moreira, A. P., Cavassani, K. A., Ismailoglu, U. B., Hullinger, R., Dunleavy, M. P., Knight, D. A., Kunkel, S. L., Uematsu, S., Akira, S., & Hogaboam, C. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44999 · Cited by 83 · cited 1×
“The MyD88 -coupled TLRs TLR1, TLR2, TLR4, TLR6 and TLR9 have been reported to contribute to fungal recognition in different experimental systems, with TLR2, TLR4 and TLR6 probabl y being the most important ones [147-150].”
BackgroundInflammation and repeated infections in CGD: two sides of a coin
Kuijpers, T. W., & Lutter, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0834-z · Cited by 82 · cited 1×
“These studies also show that the indoleamine 2,3-dioxygenase (IDO), a key enzyme of tryptophan metabolism, is involved in CGD-associated inflammation and tryptophan catabolites (kynurenines) could be therapeutically useful to regulate and dampen hyperinflammation [135,136] although the regulation of this pathway in hu…”
BackgroundBread eating induced oral angioedema due to alpha-amylase allergy.
Moreno‐Ancillo, Á., Domínguez‐Noche, C., Gil-Adrados, A. C., & Cosmes, P. M. (2004) · PubMed · Cited by 82
Mild, Moderate, and Severe Forms of Allergic Bronchopulmonary Aspergillosis
Kumar, R. (2003) · CHEST Journal · doi:10.1378/chest.124.3.890 · Cited by 81
Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis
Latzin, P., Hartl, D., Regamey, N., Frey, U., Schoeni, M. H., & Casaulta, C. (2008) · European Respiratory Journal · doi:10.1183/09031936.00078107 · Cited by 81 · cited 1×
“Clinically, CCL17 may serve as a serum biomarker in patients to differentiate sensitization to Aspergillus from clinically active ABPA flares, especially when quantified longitudinally, as supported by two studies [127,128]; cutoffs are not established.”
BackgroundSelf-citationWesterink, M. A. J., Schroeder, H. W., & Nahm, M. H. (2012) · Europe PMC (PubMed Central) · Cited by 80
Rozenbaum, M. H., van Hoek, A. J., Fleming, D., Trotter, C. L., Miller, E., & Edmunds, W. J. (2012) · BMJ · doi:10.1136/bmj.e6879 · Cited by 80 · cited 1×
“influenzae is often done, but not well studied [214-217].”
BackgroundCameron, E. J., McSharry, C. P., Chaudhuri, R., Farrow, S. N., & Thomson, N. C. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.03979.x · Cited by 77 · cited 1×
“It has been used in those with bronchiectasis, especially those with frequent exacerbations [197], as well as for other pulmonary diseases [198].”
BackgroundPneumocystis: from a doubtful unique entity to a group of highly diversified fungal species
Chabé, M., Aliouat‐Denis, C., Delhaès, L., Aliouat, E. M., Viscogliosi, É., & Dei‐Cas, E. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00698.x · Cited by 76 · cited 1×
“The application of sequence-based identification and metagenomics to studies of the human microbiome has revealed a plethora of organisms that can inhabit the human body including new or as yet unknown pathogens [100-102].”
BackgroundPASQUALOTTO, A. C., POWELL, G., NIVEN, R., & DENNING, D. W. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01640.x · Cited by 76 · cited 3×
“Furthermore, living in damp dwellings per se is associated with current asthma, lower FEV1 [88] and higher PEF variability [87].”
ResultSelf-citationPenetration of Anti-Infective Agents into PulmonaryEpithelial Lining Fluid
Rodvold, K. A., Yoo, L., & George, J. M. (2011) · Clinical Pharmacokinetics · doi:10.2165/11592900-000000000-00000 · Cited by 75
WHO universal definition of severe asthma
Bush, A., & Zar, H. J. (2011) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e32834487ae · Cited by 75 · cited 1×
“In addition, current definitions of severe asthma generally reflect treatment intensity; the WHO identified 3 patterns: 1) untreated severe asthma, due to undiagnosed asthma or unavailability of therapy, 2) difficult-to-treat severe asthma (due to adherence issues, inappropriate or incorrect use of medicines, environm…”
BackgroundPiipari, R., & Keskinen, H. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02386.x · Cited by 75 · cited 1×
“All de novo diagnosed cases of occupational asthma in Finland are obligatorily reported to the National Register, and by 2002 moulds becom e the most important causative agent (18% of cases in 1998-2002) [71].”
BackgroundAllergic Bronchopulmonary Aspergillosis After Infliximab Therapy for Sarcoidosis
Judson, M. A. (2009) · CHEST Journal · doi:10.1378/chest.08-2106 · Cited by 70
Serologic allergic bronchopulmonary aspergillosis (ABPA-S): Long-term outcomes
Agarwal, R., Garg, M. K., Aggarwal, A. N., Saikia, B., Gupta, D., & Chakrabarti, A. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.03.001 · Cited by 68 · cited 1×
“It has been thought that patients with ABPA-S represent the earliest stage of the disorder, but prolonged follow up of this group showed no interval development of bronchiectasis, despite exacerbations [56].”
BackgroundClinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis
Agarwal, R., Khan, A., Aggarwal, A. N., Varma, N., Garg, M. K., Saikia, B., Gupta, D., & Chakrabarti, A. (2011) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2011.08.006 · Cited by 67 · cited 3×
“In addition, some clinicians use expectoration of brown coloured mucus plugs as a m inor diagnostic criteria for ABPA [20], observed in 31 to 69% of patients [5].”
BackgroundInfluentialLink between CFTR mutations and ABPA: a systematic review and meta‐analysis
Agarwal, R., Khan, A., Aggarwal, A. N., & Gupta, D. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02130.x · Cited by 65 · cited 2×
“The genes implicated to date include IL-4Rα [153,154], IL-10 [155], surfactant A2 (SPA2) [156], TLR9 [30], CFTR [157-159], and HLA DR2/DR5 polymorphisms [160].”
BackgroundPhagocyte responses towards Aspergillus fumigatus
Hasenberg, M., Behnsen, J., Krappmann, S., Brakhage, A. A., & Gunzer, M. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.04.012 · Cited by 64 · cited 1×
“fumigatus invasion and are essential in restraining tissue invasion and fungal spreading from the airways into the bloodstream [123,124].”
BackgroundAgarwal, R., Khan, A., N Aggarwal, A., Saikia, B., Gupta, D., & Chakrabarti, A. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4665 · Cited by 63 · cited 2×
“A 23 patient study of ABPA patients without bronchiectasis treated with inhaled cortic osteroids showed subjective improvement but without complete control of asthma and median IgE leve ls increased [193].”
BackgroundCandida species in cystic fibrosis: A road less travelled
Chotirmall, S. H., Greene, C. M., & McElvaney, N. G. (2010) · Medical Mycology · doi:10.3109/13693786.2010.503320 · Cited by 61 · cited 1×
“These fungi can both colonize and infect the airways not only upon systemic immunosuppression, but also in pulmonary diseases where the local mucosal host defense is compromised, such as allergic asthma and cystic fibrosis [4,114-117].”
BackgroundDistribution and Severity of Bronchiectasis in Allergic Bronchopulmonary Aspergillosis (ABPA)
Mitchell, T. A. M., Hamilos, D. L., Lynch, D. A., & Newell, J. D. (2000) · Journal of Asthma · doi:10.3109/02770900009055429 · Cited by 61 · cited 1×
“The prevalence of bronchial dilatation in patients with severe or persistent asthma ranges from 17% to 30%, compared with 90% or more in ABPA [55].”
BackgroundCancer incidence among Ontario police officers
Finkelstein, M. M. (1998) · American Journal of Industrial Medicine · doi:10.1002/(sici)1097-0274(199808)34:2<183::aid-ajim12>3.0.co;2-r · Cited by 60 · cited 2×
“Studies performed in occupational settings have shown that employees mor commonly report improvement of symptoms while being away from work [179] and indic ated a reduction of respiratory symptoms including cough, shortness of breath , wheezing [185], stuffy or runny nose, eye, throat, skin, and headache symptoms [179…”
BackgroundAllergic bronchopulmonary aspergillosis: evidence of limited tissue invasion.
Riley, D. J., Mackenzie, J. W., Uhlman, W. E., & Edelman, N. H. (1975) · PubMed · doi:10.1164/arrd.1975.111.2.232 · Cited by 57 · cited 1×
“Invasive aspergillosis complicating ABPA has also been rarely described, the first time in 1975 [61].”
BackgroundPneumonia immunization in older adults: review of vaccine effectiveness and strategies
El-Solh, A., Assaad, El-Masri, & Porhomayon, J. (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s29675 · Cited by 57
The pulmonary aspergilloses: three distinct entities or a spectrum of disease.
Greene, R. E. (1981) · Radiology · doi:10.1148/radiology.140.2.7255737 · Cited by 57 · cited 1×
“Tissue damage tends to be greatest in the proxim al airway region, where mycelial plugs and antigen production are localised, giving rise t o granulomatous airway inflammation that results in the characteristic proximal bronchiectasis [49].”
BackgroundAllergic Bronchopulmonary Aspergillosis
Bains, S. N., & Judson, M. A. (2012) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2012.02.003 · Cited by 57
Allergic Bronchopulmonary Aspergillosis in Infants
Imbeau, S. A. (1977) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1977.02120230073013 · Cited by 56 · cited 1×
“Sensitization to fungi is rare in childhood, although ABPA occurs occasionally in children [44-46], as does the recently described SAFS.”
BackgroundComplexity and dynamics of host–fungal interactions
Cottier, F., & Pavelka, N. (2012) · Immunologic Research · doi:10.1007/s12026-012-8265-y · Cited by 56 · cited 1×
“Most published studies have focused on bacterial communities, but fungi also form an important component of the microbiome [103].”
BackgroundFlamant‐Hulin, M., Moularat, S., Kirchner, S., Robine, E., Mandin, C., & Annesi‐Maesano, I. (2012) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2012.02.011 · Cited by 56
Characterisation of Innate Fungal Recognition in the Lung
Faro-Trindade, I., Willment, J. A., Kerrigan, A. M., Redelinghuys, P., Hadebe, S., Reid, D. M., Srinivasan, N., Wainwright, H., Lang, D. M., Steele, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035675 · Cited by 55 · cited 2×
“A recent study shows that opsonisation with surfactant components in the lung limits inflammation by attenuating host-fungi interactions, a mechanism relevant for zymosan but not for Aspergillus species [143], underscoring the complexity of host-fungus interactions in the lung.”
BackgroundLong-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations
Serisier, D. J., & Martin, M. L. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.01.009 · Cited by 55 · cited 1×
“It has been used in those with bronchiectasis, especially those with frequent exacerbations [197], as well as for other pulmonary diseases [198].”
BackgroundDe Ravin, S. S., Zarember, K. A., Long-Priel, D., Chan, K. C., Fox, S. D., Gallin, J. I., Kuhns, D. B., & Malech, H. L. (2010) · Blood · doi:10.1182/blood-2009-07-233734 · Cited by 54
Aspergillusand asthma – any link?
Hogaboam, C. M., Carpenter, K. J., Schuh, J. M., & Buckland, K. F. (2005) · Medical Mycology · doi:10.1080/13693780400025211 · Cited by 54 · cited 1×
“These fungi can both colonize and infect the airways not only upon systemic immunosuppression, but also in pulmonary diseases where the local mucosal host defense is compromised, such as allergic asthma and cystic fibrosis [4,114-117].”
BackgroundBuilding-related symptoms and molds: a two-step intervention study
Ebbehøj, N. E., Hansen, M. O. L., Sigsgaard, T., & Larsen, L. (2002) · Indoor Air · doi:10.1034/j.1600-0668.2002.02141.x · Cited by 52 · cited 4×
“materials [179-181], applying fungicides [178], making alterations to heating [182], improving ventilation [178] and fixing buildings construction to prevent further water leakage [183] have been conducted.”
BackgroundInfluentialHomogenisation of cystic fibrosis sputum by sonication — An essential step for Aspergillus PCR
Baxter, C. G., Jones, A. M., Webb, A. K., & Denning, D. W. (2011) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2011.01.024 · Cited by 51 · cited 1×
“As such a number of groups have questioned the performance of the current UK respiratory culture methods for fungi and have called out for an improved, standardised approach [170-173].”
BackgroundSelf-citationKudoh, S., & Keicho, N. (2012) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2012.02.005 · Cited by 51
Poole, C., & Wong, M. (2013) · Occupational Medicine · doi:10.1093/occmed/kqt097 · Cited by 50 · cited 1×
“The evidence for these avoidance measures is limited [191].”
BackgroundSpecific IgE Response to Trichophyton and Asthma Severity
Matsuoka, H., Niimi, A., Matsumoto, H., Ueda, T., Takemura, M., Yamaguchi, M., Jinnai, M., Otsuka, K., Oguma, T., Takeda, T., et al. (2009) · CHEST Journal · doi:10.1378/chest.08-1783 · Cited by 49 · cited 2×
“There are multiple lines of evidence for sensitisation to Tricophyton proteins in asthma patients [39-42], where inhalation and/or dermal absorption of Trichophyton antigens are currently considered as possible routes of exposure [39,41].”
BackgroundThe remediation of mold damaged school--a three-year follow-up study on teachers' health.
Patovirta, R.-L., Husman, T. M., Haverinen‐Shaughnessy, U., Vahteristo, M., Uitti, J. A., Tukiainen, H., & Nevalainen, A. I. (2004) · PubMed · Cited by 42
Fairs, A., Agbetile, J., Bourne, M., Hargadon, B., Monteiro, W. R., Morley, J. P., Edwards, R., Wardlaw, A. J., & Pashley, C. H. (2012) · Indoor Air · doi:10.1111/ina.12020 · Cited by 41 · cited 1×
“f migatus isolation from sputum to be associated with elevated airborne levels in homes of patients with asthma [96].”
BackgroundSelf-citationRespiratory health and immunological profile of poultry workers.
Rees, D., Nelson, G., Kielkowski, D., Wasserfall, C. H., & Costa, A. D. (1998) · PubMed · Cited by 40
Chemokines in Allergic Aspergillosis - From Animal Models to Human Lung Diseases
Hartl, D., Buckland, K., & Hogaboam, C. (2006) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152806779010972 · Cited by 38 · cited 2×
“Furthermore, CCL17 has been shown to impair macrophage killing of Aspergillus [125].”
BackgroundSelf-citationEscalante, M. T., Sánchez‐Borges, M., Capriles-Hulett, A., Belfort, E., Biagio, E. D., & González-Aveledo, L. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.104381 · Cited by 37 · cited 2×
“There are multiple lines of evidence for sensitisation to Tricophyton proteins in asthma patients [39-42], where inhalation and/or dermal absorption of Trichophyton antigens are currently considered as possible routes of exposure [39,41].”
BackgroundPathology of allergic bronchopulmonary aspergillosis
Chetty, A. (2003) · Frontiers in bioscience · doi:10.2741/945 · Cited by 37 · cited 1×
“If mucoid impaction and atelectasis occur, they may be followed by bronchiolitis obliterans, granulomatous bronchiolitis, and pulmonary fibrosis [50].”
BackgroundImmunological mechanisms behind the cystic fibrosis-ABPA link
Hartl, D. (2008) · Medical Mycology · doi:10.1080/13693780802189938 · Cited by 37 · cited 1×
“In c ase of the allergic airway response to Aspergillus, the TH2-associated chemokine CCL17/TARC plays a key role in both murine and human fungal asthma [125,126].”
BackgroundSelf-citationFrequency of familial occurrence in 164 patients with allergic bronchopulmonary aspergillosis
Shah, A., Kala, J., Sahay, S., & Panjabi, C. (2008) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60311-0 · Cited by 36 · cited 2×
“Multiple associations are to be expected given a family history in 5% of those with ABPA [98].”
BackgroundStockmann, C. R., Sherwin, C. M. T., Zobell, J. T., Young, D. C., Waters, C. D., Spigarelli, M. G., & Ampofo, K. (2012) · Pediatric Pulmonology · doi:10.1002/ppul.22667 · Cited by 36 · cited 1×
“The standard registered doses of ciprofloxacin are inadequate for most patients [219,220] and high doses such as 500-750 mg three times daily are more efficient.”
BackgroundItraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis
Mannes, G. P. M., der Heide, S. V., van Aalderen, W. M. C., & Gerritsen, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90244-b · Cited by 35 · cited 1×
“Given that high incidence rates of ABPA have been reported in a number of families, such an abnormal host response is probably influenced by genetic factors [97,98].”
BackgroundSlowly decreasing mucosal hyperreactivity years after working in a school with moisture problems
Rudblad, S., Andersson, K., Stridh, G., Bodin, L., & Juto, J.-E. (2002) · Indoor Air · doi:10.1034/j.1600-0668.2002.01112.x · Cited by 35 · cited 1×
“However, other studies failed to show a beneficial effect of intervention [182,184,186].”
Background
Research works printed but not linked: 3
- 10.1111/j.1398-9995.2001.00002.x-i1 · doi:10.1111/j.1398-9995.2001.00002.x-i1 · Paper page
- Miller PW, 1996, Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis, Am J Hum Genet, 59, 45
- Foundation ERSEL, 2003, European Lung White Book
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“The major assumptions made were based on previous studies of SAFS and ABPA; Severe asthma is thought to affect about 10% of adults and in other countries, 33–70% are sensitised to fungi [137] and that 2.”
BackgroundMethodSelf-citationPatterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
“depends on patient response, severity of disease and exacerbation frequency, drug adverse effects, and the emergence of antifungal resistance [637, 639, 641].”
BackgroundSelf-citationThe Role of Lung and Gut Microbiota in the Pathology of Asthma
Barcik, W., Boutin, R. C. T., Sokolowska, M., & Finlay, B. B. (2020) · Immunity · doi:10.1016/j.immuni.2020.01.007 · Cited by 613
How to bolster the antifungal pipeline
Denning, D. W., & Bromley, M. J. (2015) · Science · doi:10.1126/science.aaa6097 · Cited by 481
Self-citationPaulussen, C., Hallsworth, J. E., Álvarez‐Pérez, S., Nierman, W. C., Hamill, P. G., Blain, D., Rediers, H., & Lievens, B. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12367 · Cited by 334
Metadata
- Authors
- Denning, D. W., Pashley, C., Hartl, D., Wardlaw, A., Godet, C., Del Giacco, S., Delhaes, L., & Sergejeva, S.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- University of Leicester (GB)
- University of Tübingen (DE)
- Centre Hospitalier Universitaire de Poitiers (FR)
- Department of Medical Sciences “M. Aresu” University of Cagliari Cagliari Italy
- Biology & Diversity of Emerging Eukaryotic Pathogens (BDEEP) Center for Infection and Immunity of Lille (CIIL), INSERM U1019, CNRS UMR8204 IFR142 Lille Pasteur Institute Lille Nord de France University (EA4547) Lille France
- North Estonia Medical Centre (EE)
- Corresponding author
- Denning, David W
- Venue
- Clinical and Translational Allergy
- Publisher
- Wiley
- Published
- 2014-01
- Volume
- 4
- Issue
- 1
- Pages
- 14-14
- ISSN
- 2045-7022 (ISSN-L)
- PMC
- PMC4005466
- OpenAlex
- W2096172855
- Cited by
- 357
- References
- 224
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 17 · 2023: 24 · 2022: 34 · 2021: 44 · 2020: 27 · 2019: 34 · 2018: 32 · 2017: 36 · 2016: 39 · 2015: 32 · 2014: 9
- FWCI
- 25.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical and Translational Allergy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Figshare (submittedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, other-oa)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion, other-oa)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0512-10030)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
- Keywords
- fungal allergy, asthma, allergic bronchopulmonary aspergillosis, fungal sensitization, fungal allergens, chronic pulmonary aspergillosis, bronchiectasis, asthma exacerbations, exposure-response relationship, genetic association, asthma management, environmental monitoring, research needs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.